Literature DB >> 29116591

Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.

Jun Zheng1,2, Yang Yang1, Meng Cui1, Zhan-Jun Shu3, Li-Li Han4, Zhen-Qiu Liu5, Charles Wood6, Tiejun Zhang7, Yan Zeng8.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the infectious etiologic agent associated with Kaposi's sarcoma (KS), primary effusion lymphoma, and multicentric Castleman disease. It has been shown that high KSHV prevalence and high incidence of both classic KS and AIDSassociated KS are found mostly among people of Uygur ethnicity in Xinjiang, while people of Han ethnicity in Xinjiang have a higher KSHV seroprevalence than those of other Han populations in mainland China. However, it is still unclear why there is such geographical and population variation in KSHV distribution in China. In this work, we focused on the populations in the Kashgar region and Urumqi area, where a total of 1294 research subjects were randomly selected to investigate the potential correlation between KSHV prevalence and different ethnicities in endemic areas of Xinjiang, and to determine risk factors that may affect KSHV infection rates or KS incidence. We identified a high seroprevalence of KSHV and high peripheral blood DNA infection in the general Uygur and Han populations in both Urumqi and Kashgar regions of Xinjiang, and determined that advancing age, low education level, and stationary population status affect KSHV infection rates. Further, KSHV-positive Uygur participants were shown to have higher prevalence of neutralizing antibodies and neutralizing antibody titers than KSHV-positive Han participants.

Entities:  

Keywords:  Han ethnicity; Kaposi’s sarcoma associated herpesvirus (KSHV); Uygur ethnicity; Xinjiang; prevalence

Mesh:

Substances:

Year:  2017        PMID: 29116591      PMCID: PMC6704202          DOI: 10.1007/s12250-017-4049-9

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China
  29 in total

1.  [Antibody to human herpesvirus type-8 in the general populations of Xinjiang Autonomous Region(A.R.)].

Authors:  W Du; G Chen; H Sun
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2000-03

2.  Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.

Authors:  Fangping He; Xing Wang; Bin He; Zongdi Feng; Xiaomei Lu; Yaoxin Zhang; Shujun Zhao; Renyong Lin; Yan Hui; Yongxing Bao; Zhaoxia Zhang; Hao Wen
Journal:  J Med Virol       Date:  2007-02       Impact factor: 2.327

3.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas.

Authors:  J Baillargeon; J H Deng; E Hettler; C Harrison; J J Grady; L G Korte; J Alexander; E Montalvo; H B Jenson; S J Gao
Journal:  Ann Epidemiol       Date:  2001-10       Impact factor: 3.797

4.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.

Authors:  Zhenqiu Liu; Qiwen Fang; Sujuan Zhou; Veenu Minhas; Charles Wood; Na He; Tiejun Zhang
Journal:  J Med Virol       Date:  2017-04-11       Impact factor: 2.327

5.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

6.  Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users.

Authors:  A Zavitsanou; M Malliori; V Sypsa; M Petrodaskalaki; M Psichogiou; C Rokka; A Giannopoulos; V Kalapothaki; D Whitby; A Hatzakis
Journal:  Epidemiol Infect       Date:  2009-08-24       Impact factor: 2.451

7.  Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.

Authors:  Louise E Kimball; Corey Casper; David M Koelle; Rhoda Morrow; Lawrence Corey; Jeffrey Vieira
Journal:  J Infect Dis       Date:  2004-05-11       Impact factor: 5.226

8.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.

Authors:  D Whitby; M R Howard; M Tenant-Flowers; N S Brink; A Copas; C Boshoff; T Hatzioannou; F E Suggett; D M Aldam; A S Denton
Journal:  Lancet       Date:  1995-09-23       Impact factor: 79.321

9.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic.

Authors:  P Cook-Mozaffari; R Newton; V Beral; D P Burkitt
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more
  5 in total

1.  Herpesviruses: epidemiology, pathogenesis, and interventions.

Authors:  Ke Lan; Min-Hua Luo
Journal:  Virol Sin       Date:  2017-10       Impact factor: 4.327

2.  Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2.

Authors:  Soo Mi Lee; Kenneth M Kaye; Frank J Slack
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 11.205

3.  Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.

Authors:  Salum J Lidenge; Andrew V Kossenkov; For Yue Tso; Jayamanna Wickramasinghe; Sara R Privatt; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Paul M Lieberman; John T West; Charles Wood
Journal:  PLoS Pathog       Date:  2020-07-24       Impact factor: 6.823

4.  Classic Kaposi sarcoma in a patient of Miao ethnicity followed up for 7 years: a case report.

Authors:  Jing Zhou; Xiaoping Shen; Xiaodong Wang; Kun Xiao; Yu Cao; Yanping Jiang
Journal:  J Med Case Rep       Date:  2021-04-19

Review 5.  Evidence for altered host genetic factors in KSHV infection and KSHV-related disease development.

Authors:  Melissa J Blumenthal; Elena Maria Cornejo Castro; Denise Whitby; Arieh A Katz; Georgia Schäfer
Journal:  Rev Med Virol       Date:  2020-10-11       Impact factor: 6.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.